Improved results following liver transplantation (LT) over the past 20 years have led clinicians to push boundaries and expand itsindications. LT in non-resectable colorectal liver metastases (NCRLM) is being revisited with an aim to radically improve survival.By utilizing new tools for preoperative patient selection, modern operative techniques for LT and an aggressive attitude againstmetastases, long-term survival, and even cure could be expected. This paper reviews the current status of liver transplantation forNCRLM with an eye on the future
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients developing metast...
Liver transplantation (LT) for unresectable colorectal liver metastases has long been abandoned beca...
Backgrounds Colorectal liver metastases were historically considered a contraindication to liver tra...
Colorectal cancer (CRC) is the third most incident cancer worldwide. Most of CRC patients will devel...
Background: Liver transplantation (LT) has gained interest in the treatment of unresectable colorec...
Liver transplantation (LT) has become the standard of care for selected primary and secondary malign...
Historically, colorectal cancer liver metastases have been considered a terminal disease. In the las...
The rapid progression in the development of liver transplantation during the last decade is largely ...
The development of liver metastases in colon rectal cancer has a strong impact on the overall surviv...
International audiencePatients with nonresectable liver metastases from colorectal cancer have few t...
As transplant medicine has evolved in recent decades so too have the indications for liver transplan...
Importance: Colorectal cancer is a leading cause of cancer-related death, and nearly 70% of patients...
Background: Non-resectable CRLM is a common and severe manifestation of colorectal cancer associated...
Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients developing metast...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients developing metast...
Liver transplantation (LT) for unresectable colorectal liver metastases has long been abandoned beca...
Backgrounds Colorectal liver metastases were historically considered a contraindication to liver tra...
Colorectal cancer (CRC) is the third most incident cancer worldwide. Most of CRC patients will devel...
Background: Liver transplantation (LT) has gained interest in the treatment of unresectable colorec...
Liver transplantation (LT) has become the standard of care for selected primary and secondary malign...
Historically, colorectal cancer liver metastases have been considered a terminal disease. In the las...
The rapid progression in the development of liver transplantation during the last decade is largely ...
The development of liver metastases in colon rectal cancer has a strong impact on the overall surviv...
International audiencePatients with nonresectable liver metastases from colorectal cancer have few t...
As transplant medicine has evolved in recent decades so too have the indications for liver transplan...
Importance: Colorectal cancer is a leading cause of cancer-related death, and nearly 70% of patients...
Background: Non-resectable CRLM is a common and severe manifestation of colorectal cancer associated...
Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients developing metast...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients developing metast...
Liver transplantation (LT) for unresectable colorectal liver metastases has long been abandoned beca...